Last updated on September 2015
Lupus Nephritis
Brief description of study
Lupus Nephritis
Detailed Study Description
The drug being tested is called belimumab. It is a prescription medicine to treate active systemic lupus erythematosus who are receiving other lupus medicines. The purpose of the study is to find out if belimumab is effective and safe in treating patients with active lupus nephritis who are receiving other standard lupus nephritis medicines.
Clinical Study Identifier: TX141478
Start Over
Connect »